The Medical Letter Online

Tag: Authorised

Human medicines European Public Assessment Report (EPAR): Protopic, tacrolimus, Revision: 15, Authorised

| October 26, 2012 | 0 Comments

Pending EC decisions and European Public Assessment Reports (EPARs): Human medicinal products

Continue Reading

Human medicines European Public Assessment Report (EPAR): Cialis, tadalafil, Revision: 14, Authorised

| October 23, 2012 | 0 Comments

Pending EC decisions and European Public Assessment Reports (EPARs): Human medicinal products

Continue Reading

Human medicines European Public Assessment Report (EPAR): Flebogamma DIF (previously Flebogammadif), human normal immunoglobulin, Revision: 7, Authorised

| October 21, 2012 | 0 Comments

Pending EC decisions and European Public Assessment Reports (EPARs): Human medicinal products

Continue Reading

Human medicines European Public Assessment Report (EPAR): Eklira Genuair, aclidinium bromide, Revision: 0, Authorised

| October 19, 2012 | 0 Comments

Pending EC decisions and European Public Assessment Reports (EPARs): Human medicinal products

Continue Reading

Human medicines European Public Assessment Report (EPAR): Inlyta, axitinib, Revision: 0, Authorised

| October 13, 2012 | 0 Comments

Pending EC decisions and European Public Assessment Reports (EPARs): Human medicinal products

Continue Reading

Human medicines European Public Assessment Report (EPAR): Instanyl, fentanyl, Revision: 6, Authorised

| September 30, 2012 | 0 Comments

Pending EC decisions and European Public Assessment Reports (EPARs): Human medicinal products

Continue Reading

Human medicines European Public Assessment Report (EPAR): Victrelis, boceprevir, Revision: 3, Authorised

| September 29, 2012 | 0 Comments

Pending EC decisions and European Public Assessment Reports (EPARs): Human medicinal products

Continue Reading

Human medicines European Public Assessment Report (EPAR): Zonegran, zonisamide, Revision: 21, Authorised

| September 26, 2012 | 0 Comments

Pending EC decisions and European Public Assessment Reports (EPARs): Human medicinal products

Continue Reading

Human medicines European Public Assessment Report (EPAR): Rienso, ferumoxytol, Revision: 2, Authorised

| September 25, 2012 | 0 Comments

Pending EC decisions and European Public Assessment Reports (EPARs): Human medicinal products

Continue Reading

Human medicines European Public Assessment Report (EPAR): Ceplene, histamine dihydrochloride, Revision: 5, Authorised

| September 22, 2012 | 0 Comments

Pending EC decisions and European Public Assessment Reports (EPARs): Human medicinal products

Continue Reading